Keros Therapeutics, Inc. in 1 story
The narratives KROS currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
KROS in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Keros is developing muscle-preservation therapies that could complement GLP-1 drugs by limiting the lean-mass loss associated with rapid weight reduction.
Bear side
0 storiesNo bear-side stories for KROS yet.